| 2024-11-12 | -43.2% | earnings | Seeking Alpha | Rockwell Medical, Inc. (RMTI) Q3 2024 Earnings Call Transcript |
| 2024-11-12 | -43.2% | earnings | Seeking Alpha | Rockwell Medical Non-GAAP EPS of $0.09, revenue of $28.32M beats by $1.82M |
| 2024-11-12 | -43.2% | legal | SEC EDGAR | RMTI 8-K: 2.02 and (SEC Filing) |
| 2026-01-20 | +29.0% | earnings | Seeking Alpha | Rockwell Medical's Q4 preliminary sales beat estimates |
| 2026-01-20 | +29.0% | legal | SEC EDGAR | RMTI 8-K: 2.02 and (SEC Filing) |
| 2026-01-20 | +29.0% | news | Stock Titan | Dialysis supplier Rockwell Medical ends 2025 with $25M cash cushion - Stock Titan |
| 2026-01-20 | +29.0% | earnings | Investing.com | Rockwell Medical stock jumps after positive preliminary Q4 results - Investing.com |
| 2026-01-20 | +29.0% | news | timothysykes.com | Rockwell Medical Expands Westward Amid Supply Chain Challenges - timothysykes.com |
| 2026-01-20 | +29.0% | earnings | GuruFocus | Rockwell Medical (RMTI) Anticipates Strong Q4 Financial Performa - GuruFocus |
| 2022-11-14 | +28.2% | legal | SEC EDGAR | RMTI 8-K: 2.02 and (SEC Filing) |
| 2025-03-20 | -22.7% | earnings | Seeking Alpha | Rockwell medical projects $65M-$70M revenue in 2025 amid strategic shifts |
| 2025-03-20 | -22.7% | earnings | Seeking Alpha | Rockwell Medical, Inc. (RMTI) Q4 2024 Earnings Call Transcript |
| 2025-03-20 | -22.7% | earnings | Seeking Alpha | Rockwell Medical Non-GAAP EPS of $0.04, revenue of $24.67M beats by $1.02M |
| 2025-03-20 | -22.7% | legal | SEC EDGAR | RMTI 8-K: 2.02 and (SEC Filing) |
| 2025-03-20 | -22.7% | news | Business Wire | Rockwell Medical Announces Fourth Quarter and Full-Year 2024 Financial and Operational Results - Business Wire |
| 2025-03-19 | -19.9% | earnings | Seeking Alpha | Rockwell Medical Q4 Earnings Preview |
| 2026-03-16 | +16.5% | executive | Stock Titan | Rockwell Medical (RMTI) CFO has shares withheld to cover taxes - Stock Titan |
| 2025-05-09 | -14.3% | earnings | Seeking Alpha | Rockwell Medical Q1 Earnings Preview |
| 2026-03-26 | -12.9% | earnings | GuruFocus.com | Rockwell Medical Inc (RMTI) Q4 2025 Earnings Call Highlights: Navigating Challenges with ... |
| 2026-03-26 | -12.9% | earnings | Moby | Rockwell Medical, Inc. Q4 2025 Earnings Call Summary |
| 2026-03-26 | -12.9% | earnings | Zacks | Rockwell Medical (RMTI) Reports Q4 Loss, Misses Revenue Estimates |
| 2026-03-26 | -12.9% | earnings | Associated Press Finance | Rockwell Medical: Q4 Earnings Snapshot |
| 2026-03-26 | -12.9% | news | Business Wire | Rockwell Medical Announces Fourth Quarter and Full-Year 2025 Financial and Operational Results |
| 2026-03-26 | -12.9% | news | Seeking Alpha | Rockwell Medical targets $1M–$2M adjusted EBITDA and positive cash flow in 2026 as product mix diversifies |
| 2026-03-26 | -12.9% | earnings | Seeking Alpha | Rockwell Medical, Inc. (RMTI) Q4 2025 Earnings Call Transcript |
| 2026-03-26 | -12.9% | earnings | Seeking Alpha | Rockwell Medical misses top-line estimates; gives FY26 outlook |
| 2026-03-26 | -12.9% | legal | SEC EDGAR | RMTI 8-K: 2.02 and (SEC Filing) |
| 2026-03-26 | -12.9% | earnings | Quiver Quantitative | ROCKWELL MEDICAL ($RMTI) Releases Q4 2025 Earnings | RMTI Stock News - Quiver Quantitative |
| 2026-03-26 | -12.9% | earnings | Stock Titan | Rockwell Medical (RMTI) posts 2025 revenue decline but stronger margins and cash - Stock Titan |
| 2026-03-26 | -12.9% | earnings | MSN | Rockwell Medical tops earnings forecasts but shares slip on revenue decline - MSN |
| 2026-03-26 | -12.9% | earnings | Investing.com | Earnings call transcript: Rockwell Medical Q4 2025 beats EPS forecast - Investing.com |
| 2026-03-26 | -12.9% | news | TipRanks | Rockwell Med Updates Corporate Presentation for Investors - TipRanks |
| 2026-03-26 | -12.9% | news | TipRanks | Rockwell Medical’s Cost Cuts Raise Execution Risk and Threaten Future Growth Prospects - TipRanks |
| 2023-03-30 | +12.6% | legal | SEC EDGAR | RMTI 8-K: 2.02 and (SEC Filing) |
| 2025-11-12 | -11.7% | expansion | Seeking Alpha | Rockwell Medical outlines $1M annual contract and West Coast expansion as transition continues |
| 2025-11-12 | -11.7% | earnings | Seeking Alpha | Rockwell Medical, Inc. (RMTI) Q3 2025 Earnings Call Transcript |
| 2025-11-12 | -11.7% | earnings | Seeking Alpha | Rockwell Medical Non-GAAP EPS of $0.00, revenue of $15.93M misses by $0.31M; reaffirms FY outlook |
| 2025-11-12 | -11.7% | legal | SEC EDGAR | RMTI 8-K: 2.02 and (SEC Filing) |
| 2025-11-12 | -11.7% | earnings | Yahoo Finance | Rockwell Medical Inc (RMTI) Q3 2025 Earnings Call Highlights: Navigating Challenges and Seizing ... - Yahoo Finance |
| 2025-11-12 | -11.7% | news | Business Wire | Rockwell Medical Announces Third Quarter 2025 Results - Business Wire |
| 2022-04-08 | -11.7% | legal | SEC EDGAR | RMTI 8-K: 1.01, 3.02, 3.03, 5.03 (SEC Filing) |
| 2024-11-13 | -11.4% | analyst | Seeking Alpha | This microcap healthcare stock could double in value by 2027, analyst says |
| 2024-11-13 | -11.4% | news | Seeking Alpha | Rockwell Medical's Dip Gives A Speculative Opportunity |
| 2024-11-13 | -11.4% | legal | SEC EDGAR | RMTI 8-K: 8.01 and (SEC Filing) |
| 2022-08-15 | +11.3% | legal | SEC EDGAR | RMTI 8-K: 2.02 and (SEC Filing) |
| 2025-11-11 | -10.6% | earnings | Seeking Alpha | Rockwell Medical Q3 Earnings Preview |
| 2023-11-14 | +10.0% | legal | SEC EDGAR | RMTI 8-K: 2.02 and (SEC Filing) |
| 2024-01-08 | -9.8% | legal | SEC EDGAR | RMTI 8-K: 1.01, 2.02, 2.03, 3.02, 8.01 (SEC Filing) |
| 2022-08-03 | +9.1% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for Rockwell Medical (RMTI) - Zacks Investment Research |
| 2025-05-12 | -8.5% | earnings | Seeking Alpha | Rockwell Medical reiterates $65M–$70M 2025 sales guidance while pursuing new customers and product expansion |
| 2025-05-12 | -8.5% | earnings | Seeking Alpha | Rockwell Medical, Inc. (RMTI) Q1 2025 Earnings Call Transcript |
| 2025-05-12 | -8.5% | earnings | Seeking Alpha | Rockwell Medical Non-GAAP EPS of -$0.01, revenue of $18.91M beats by $1.45M |
| 2025-05-12 | -8.5% | legal | SEC EDGAR | RMTI 8-K: 2.02 and (SEC Filing) |
| 2026-02-03 | -8.3% | news | simplywall.st | Rockwell Medical, Inc.'s (NASDAQ:RMTI) Shares Bounce 32% But Its Business Still Trails The Industry - simplywall.st |
| 2021-11-15 | -8.1% | legal | SEC EDGAR | RMTI 8-K: 2.02 and (SEC Filing) |
| 2025-08-13 | +7.9% | earnings | Seeking Alpha | Rockwell Medical Q2 Earnings Preview |
| 2022-10-13 | -7.7% | news | GuruFocus | David S. Richmond Net Worth (2026) - GuruFocus |
| 2026-03-27 | -7.5% | news | Zacks | Should Value Investors Buy Rockwell Medical (RMTI) Stock? |
| 2026-03-27 | -7.5% | news | Zacks | Fast-paced Momentum Stock Rockwell Medical (RMTI) Is Still Trading at a Bargain |
| 2026-03-27 | -7.5% | news | Yahoo Finance | Should Value Investors Buy Rockwell Medical (RMTI) Stock? - Yahoo Finance |
| 2026-03-25 | -7.5% | earnings | Seeking Alpha | Rockwell Medical Q4 Earnings Preview |
| 2024-12-17 | +7.4% | expansion | Seeking Alpha | Rockwell Medical sees over $10M net sales in 2025 from product purchase agreement |
| 2022-04-11 | -7.2% | legal | SEC EDGAR | RMTI 8-K: 1.01 and (SEC Filing) |
| 2026-01-22 | -7.1% | analyst | The Globe and Mail | Analysts Offer Insights on Healthcare Companies: Rockwell Med (RMTI), Mediwound (MDWD) and Semler Scientific (SMLR) - The Globe and Mail |
| 2025-09-30 | -7.0% | executive | Seeking Alpha | Rockwell Medical promotes Heather Hunter to COO |
| 2026-01-05 | +6.9% | legal | SEC EDGAR | RMTI 8-K: 8.01 (SEC Filing) |
| 2026-01-05 | +6.9% | news | Stock Titan | Dialysis provider extends supply pact with Rockwell Medical to 2026 - Stock Titan |
| 2026-01-05 | +6.9% | expansion | TipRanks | Rockwell Medical Extends DaVita Supply Agreement with Price Increase - TipRanks |
| 2023-08-14 | -6.8% | legal | SEC EDGAR | RMTI 8-K: 2.02 and (SEC Filing) |
| 2023-07-11 | -6.6% | legal | SEC EDGAR | RMTI 8-K: 1.01, 2.02, 3.02, 3.03, 7.01, 8.01 (SEC Filing) |
| 2025-09-29 | -6.2% | legal | SEC EDGAR | RMTI 8-K: 5.02 and (SEC Filing) |
| 2023-09-15 | -5.9% | legal | SEC EDGAR | RMTI 8-K: 5.02 (SEC Filing) |
| 2021-08-16 | -5.7% | legal | SEC EDGAR | RMTI 8-K: 2.02 and (SEC Filing) |
| 2021-12-14 | -5.5% | legal | SEC EDGAR | RMTI 8-K: 8.01 and (SEC Filing) |
| 2022-11-30 | +5.2% | news | GuruFocus | Marc L Hoffman Net Worth (2026) - GuruFocus |
| 2026-01-28 | -5.0% | news | Yahoo Finance | Is Rockwell Medical (RMTI) Stock Undervalued Right Now? - Yahoo Finance |
| 2024-07-09 | +5.0% | news | 24/7 Wall St. | 3 Penny Stocks With 735% Average Upside, According to Wall Street - 24/7 Wall St. |
| 2021-09-30 | -5.0% | legal | SEC EDGAR | RMTI 8-K: 1.01, 2.03 (SEC Filing) |
| 2024-11-15 | -4.7% | M&A | GuruFocus | ARMISTICE CAPITAL, LLC Acquires Significant Stake in Rockwell Me - GuruFocus |
| 2025-11-15 | -4.5% | earnings | Seeking Alpha | Rockwell Medical, Inc. 2025 Q3 - Results - Earnings Call Presentation |
| 2026-01-06 | -4.3% | analyst | Investing.com | H.C. Wainwright reiterates Buy rating on Rockwell Medical stock - Investing.com |
| 2022-03-21 | +4.3% | legal | SEC EDGAR | RMTI 8-K: 5.02 (SEC Filing) |
| 2023-05-15 | -4.2% | legal | SEC EDGAR | RMTI 8-K: 2.02 and (SEC Filing) |
| 2026-04-09 | -3.7% | news | Business Wire | Rockwell Medical to Release First Quarter 2026 Results on Thursday, May 7, 2026 |
| 2026-04-09 | -3.7% | earnings | Stock Titan | Rockwell Medical to post Q1 results at 6 a.m., host webcast at 8 - Stock Titan |
| 2024-05-11 | +3.6% | earnings | MarketBeat | Rockwell Medical (RMTI) Stock Forecast and Price Target 2026 $RMTI - MarketBeat |
| 2026-04-20 | -3.5% | news | Stock Titan | [PRE 14A] ROCKWELL MEDICAL, INC. Preliminary Proxy Statement - Stock Titan |
| 2024-03-21 | +3.5% | legal | SEC EDGAR | RMTI 8-K: 2.02 and (SEC Filing) |
| 2023-10-17 | -3.5% | legal | SEC EDGAR | RMTI 8-K: 5.02 (SEC Filing) |
| 2022-06-02 | -3.3% | legal | SEC EDGAR | RMTI 8-K: 1.01, 3.02 (SEC Filing) |
| 2024-07-15 | -3.2% | legal | SEC EDGAR | RMTI 8-K: 1.01, 7.01 (SEC Filing) |
| 2025-12-17 | +2.8% | news | simplywall.st | Is Rockwell Medical (NASDAQ:RMTI) A Risky Investment? - simplywall.st |
| 2025-08-14 | -2.6% | earnings | Seeking Alpha | Rockwell Medical reiterates $65M-$70M sales target for 2025 as new contracts expand long-term revenue base |
| 2025-08-14 | -2.6% | earnings | Seeking Alpha | Rockwell Medical, Inc. (RMTI) Q2 2025 Earnings Call Transcript |
| 2025-08-14 | -2.6% | earnings | Seeking Alpha | Rockwell Medical Non-GAAP EPS of -$0.01, revenue of $16.07M misses by $0.26M |
| 2025-08-14 | -2.6% | legal | SEC EDGAR | RMTI 8-K: 2.02 and (SEC Filing) |
| 2026-02-26 | -2.2% | news | Business Wire | Rockwell Medical to Release Fourth Quarter and Full-Year 2025 Results on Thursday, March 26, 2026 |
| 2026-03-28 | -2.0% | earnings | Seeking Alpha | Rockwell Medical, Inc. 2025 Q4 - Results - Earnings Call Presentation |
| 2026-03-28 | -2.0% | earnings | Seeking Alpha | Rockwell Medical, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:RMTI) 2026-03-28 - Seeking Alpha |
| 2022-03-18 | +1.9% | legal | SEC EDGAR | RMTI 8-K: 5.02 (SEC Filing) |
| 2023-09-21 | +1.9% | legal | SEC EDGAR | RMTI 8-K: 1.01 (SEC Filing) |
| 2026-02-16 | +1.8% | news | Zacks | Why Fast-paced Mover Rockwell Medical (RMTI) Is a Great Choice for Value Investors |
| 2026-02-16 | +1.8% | news | Yahoo Finance | Why Fast-paced Mover Rockwell Medical (RMTI) Is a Great Choice for Value Investors - Yahoo Finance |
| 2023-08-02 | -1.5% | news | TradingView | Diluted shares outstanding of Rockwell Medical, Inc. – NASDAQ:RMTI - TradingView |
| 2022-06-22 | +1.5% | legal | SEC EDGAR | RMTI 8-K: 3.02, 5.02, 8.01 (SEC Filing) |
| 2022-05-16 | +1.3% | legal | SEC EDGAR | RMTI 8-K: 2.02 and (SEC Filing) |
| 2026-04-17 | +1.2% | news | Stock Titan | 85,000 PSUs tied to stock-price goals at Rockwell Medical (RMTI) - Stock Titan |
| 2026-04-17 | +1.2% | executive | Stock Titan | Rockwell Medical (RMTI) CEO awarded 352,000 performance-based stock units - Stock Titan |
| 2026-04-17 | +1.2% | news | Stock Titan | Rockwell Medical (RMTI) EVP awarded 97,500 performance-based RSUs tied to stock - Stock Titan |
| 2026-04-17 | +1.2% | executive | Stock Titan | Rockwell Medical (RMTI) awards CFO 97,500 performance-based stock units - Stock Titan |
| 2024-05-14 | -1.1% | legal | SEC EDGAR | RMTI 8-K: 2.02 and (SEC Filing) |
| 2021-05-17 | -1.1% | legal | SEC EDGAR | RMTI 8-K: 2.02 and (SEC Filing) |
| 2024-09-15 | -0.9% | news | Seeking Alpha | Rockwell Medical Stock: Turnaround Looks Real (NASDAQ:RMTI) - Seeking Alpha |
| 2025-08-19 | +0.8% | news | simplywall.st | Rockwell Medical, Inc. (NASDAQ:RMTI) Shares Could Be 34% Below Their Intrinsic Value Estimate - simplywall.st |
| 2026-04-23 | +0.8% | earnings | Cổng thông tin điện tử tỉnh Tây Ninh | Rockwell Medical (RMTI) Comprehensive Review | Q4 2025: Profit Disappoints - Dividend Report - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2026-02-13 | +0.7% | news | Yahoo Finance | Are Investors Undervaluing Rockwell Medical (RMTI) Right Now? - Yahoo Finance |
| 2025-11-18 | -0.7% | legal | SEC EDGAR | RMTI 8-K: 5.02 (SEC Filing) |
| 2024-03-26 | +0.6% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2024-12-12 | +0.5% | executive | Seeking Alpha | Rockwell Medical names new finance chief |
| 2024-12-12 | +0.5% | legal | SEC EDGAR | RMTI 8-K: 5.02 and (SEC Filing) |
| 2024-07-21 | +0.5% | earnings | Seeking Alpha | Rockwell Medical Looks Like A Speculative Buy As It Approaches Profitability (NASDAQ:RMTI) - Seeking Alpha |
| 2026-03-30 | -0.3% | earnings | Investing.com | H.C. Wainwright cuts Rockwell Medical stock price target to $2 on sales miss - Investing.com |
| 2026-04-26 | — | analyst | MSN | Rockwell Medical (RMTI) price target decreased by 20.00% to 3.06 - MSN |
| 2026-04-26 | — | earnings | MSN | Rockwell Medical (RMTI) reports Q4 loss, misses revenue estimates - MSN |